Significantly Worse Colostomy-Free Survival in Human Immunodeficiency Virus Positive Patients After Definitive Chemoradiation for Anal Cancer

被引：1
|
作者：
Grew, D. [1 ]
Bitterman, D. [1 ]
Leichman, C. [1 ]
Leichman, L. [1 ]
Du, K. [1 ]
机构：
[1] NYU Med Ctr, New York, NY 10016 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2467
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [21] Cancer Risk Stratification of Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus-Positive Men by Validated Methylation Markers Associated With Progression to Cancer
    van der Zee, Ramon P.
    Richel, Olivier
    van Noesel, Carel J. M.
    Ciocanea-Teodorescu, Iuliana
    van Splunter, Annina P.
    Ter Braak, Timo J.
    Nathan, Mayura
    Cuming, Tamzin
    Sheaff, Michael
    Kreuter, Alexander
    Meijer, Chris J. L. M.
    Quint, Wim G., V
    de Vries, Henry J. C.
    Prins, Jan M.
    Steenbergen, Renske D. M.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2154 - 2163
  • [22] Analytics for Progression Free Survival and Distant Metastasis Prediction of Anal Cancer Patients After Chemoradiation Therapy Using Spatial Temporal FDG-PET/CT Features
    Chuong, M. D.
    Zhang, H. H.
    Wang, J.
    Latifi, K.
    Saeed, N.
    Tan, S.
    Choi, W.
    Hoffe, S. E.
    Shridhar, R.
    Lu, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E158 - E159
  • [23] Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
    B. Weixler
    R. Warschkow
    U. Güller
    A. Zettl
    U. von Holzen
    B. M. Schmied
    M. Zuber
    BMC Cancer, 16
  • [24] Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
    Weixler, B.
    Warschkow, R.
    Gueller, U.
    Zettl, A.
    von Holzen, U.
    Schmied, B. M.
    Zuber, M.
    BMC CANCER, 2016, 16
  • [25] Functional Outcomes and Quality of Life After Definitive Chemoradiation for Human Papillomavirus-Positive Oropharyngeal Cancer: Implications for Dose De-escalation
    Chen, A. M.
    Daly, M. E.
    Farwell, G.
    Luu, Q.
    Donald, P. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S609 - S609
  • [26] Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
    Duclos-Vallee, Jean-Charles
    Feray, Cyrille
    Sebagh, Mylene
    Teicher, Elina
    Roque-Afonso, Anne-Marie
    Roche, Bruno
    Azoulay, Daniel
    Adam, Rene
    Bismuth, Henri
    Castaing, Denis
    Vittecoq, Daniel
    Satnuel, Didier
    HEPATOLOGY, 2008, 47 (02) : 407 - 417
  • [27] Immunological Response of Human Immunodeficiency Virus Positive Patients after Initiation of Highly Active Antiretroviral Therapy
    Reddy, K. B. Yadavendra
    Visalakshi, B.
    Kirankumar, P.
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2015, 3 (07) : 117 - 120
  • [28] Preliminary Results of Radiation Therapy for Prostate Cancer in Human Immunodeficiency Virus-Positive Patients REPLY
    Ng, Tracy
    Berson, Anthony M.
    Stein, Nicholas F.
    McDermott, Bill
    UROLOGY, 2008, 72 (05) : 1138 - 1138
  • [29] Oncological features and prognosis of colorectal cancer in human immunodeficiency virus-positive patients: A retrospective study
    Yang, Fu-Yu
    He, Fan
    Chen, De-Fei
    Tang, Cheng-Lin
    Woraikat, Saed
    Li, Yao
    Qian, Kun
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (01):
  • [30] Human Immunodeficiency Virus (HIV) Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer
    Salahuddin, Syim
    Cohen, Oded
    Wu, Margaret
    Irizarry, Javier Perez
    Vega, Teresita
    Gan, Geliang
    Deng, Yanhong
    Isaeva, Natalia
    Prasad, Manju
    Schalper, Kurt A.
    Mehra, Saral
    Yarbrough, Wendell G.
    Emu, Brinda
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) : 1449 - 1458
12345